logo

Search

Login | Create Account

rheumatology


Categories

Bone health Gout JIA Lupus Medicines Medicopolitical Musculoskeletal Osteoarthritis Pain Psoriatic arthritis Public health Rare diseases Research Rheumatoid arthritis Risk factors Scleroderma Spondyloarthritis

Other

Conferences

Specialties


Cardiology Dermatology Endocrinology Gastroenterology Haematology Neurology Oncology Respiratory Rheumatology

General


Contact Us About Us Website Disclaimer Privacy Policy Terms & Conditions

©2022 the limbic

logo

EULAR 2021

Wednesday 2nd - Saturday 5th June 2021

EULAR 2021 Virtual Congress

Rare diseases

Antifibrotic agent slows progression of RA-ILD

Nintedanib slows the rate of decline in forced vital capacity (FVC) in patients with progressive fibrosing RA associated interstitial lung disease (RA-ILD), according to data presented at EULAR 2021. The subanalysis of the INBUILD trial comprised 89 patients with RA-ILD of...

Nintedanib slows the rate of decline in forced vital capacity (FVC) in patients with progressive fibrosing RA associated interstitial lung...


Psoriatic arthritis

EULAR 2021: Enthusiasm for FMT not matched by results in psoriatic arthritis

Faecal microbiota transplantation (FMT) offers no advantage for patients with active peripheral psoriatic arthritis. The findings challenge enthusiasm for a relationship between microbial dysbiosis and joint inflammation as per gut inflammation. The FLORA trial, presented at EULAR 2021, evaluated the effectiveness and...

Faecal microbiota transplantation (FMT) offers no advantage for patients with active peripheral psoriatic arthritis. The findings challenge enthusiasm for a relationship...


Cancel
Cancel